{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:47:28Z","timestamp":1791398848035,"version":"4.3.3"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21430760800"],"award-info":[{"award-number":["21430760800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872826"],"award-info":[{"award-number":["81872826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030107"],"award-info":[{"award-number":["82030107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273867"],"award-info":[{"award-number":["82273867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2023.01.022","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:37:21Z","timestamp":1673530641000},"page":"279-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["\u201cHook&amp;Loop\u201d multivalent interactions based on disk-shaped nanoparticles strengthen active targeting"],"prefix":"10.1016","volume":"354","author":[{"given":"Ni","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.01.022_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jconrel.2022.06.035","article-title":"35 years of discussions with prof. Maeda on the EPR effect and future directions","volume":"348","author":"Matsumura","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0015","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.018","article-title":"Advanced drug delivery 2020 and beyond: perspectives on the future","volume":"158","author":"Bae","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0030","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1021\/nn404501g","article-title":"Facing the truth about nanotechnology in drug delivery","volume":"7","author":"Park","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0040","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0050","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0055","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3762\/bjnano.5.161","article-title":"In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far?","volume":"5","author":"Nazarenus","year":"2014","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0060","first-page":"1289","article-title":"Virus entry at a glance","volume":"126","author":"Yamauchi","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0065","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.addr.2012.08.005","article-title":"Interactions of nanomaterials and biological systems: implications to personalized nanomedicine","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0070","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.bpj.2018.03.007","article-title":"Multivalent binding of a ligand-coated particle: role of shape, size, and ligand heterogeneity","volume":"114","author":"McKenzie","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biomaterials.2017.10.024","article-title":"Overcoming obstacles in the tumor microenvironment: recent advancements in nanoparticle delivery for cancer theranostics","volume":"156","author":"Overchuk","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.11.010","article-title":"A quantitative view on multivalent nanomedicine targeting","volume":"169","author":"Woythe","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/asia.201801677","article-title":"Designing multivalent ligands to control biological interactions: from vaccines and cellular effectors to targeted drug delivery","volume":"14","author":"Arsiwala","year":"2019","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0090","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1002\/anie.201201114","article-title":"Multivalency as a chemical organization and action principle","volume":"51","author":"Fasting","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0095","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1021\/acs.langmuir.8b02707","article-title":"Kinetics of nanoparticle-membrane adhesion mediated by multivalent interactions","volume":"35","author":"Lanfranco","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.apsb.2021.03.007","article-title":"Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0110","doi-asserted-by":"crossref","first-page":"1706709","DOI":"10.1002\/adma.201706709","article-title":"Multivalent interactions between 2D nanomaterials and biointerfaces","volume":"30","author":"Tu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0115","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.1308345110","article-title":"Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium","volume":"110","author":"Kolhar","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0120","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1039\/D1CS00659B","article-title":"Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?","volume":"51","author":"Vallet-Regi","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0125","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1016\/j.cclet.2021.06.034","article-title":"New advances in gated materials of mesoporous silica for drug controlled release","volume":"32","author":"Huang","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0130","article-title":"Cell membrane-coated mesoporous silica nanorods overcome sequential drug delivery barriers against colorectal cancer","volume":"107828","author":"Wang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0135","article-title":"Red blood cell inspired strategies for drug delivery: emerging concepts and new advances","volume":"11095","author":"Zhang","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114394","article-title":"Cell-based drug delivery systems and their in vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.09.009","article-title":"Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology","volume":"116","author":"Huang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actbio.2021.10.011","article-title":"Our contributions to applications of mesoporous silica nanoparticles","volume":"137","author":"Vallet-Regi","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0155","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0160","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jconrel.2022.09.005","article-title":"Shape-directed drug release and transport of erythrocyte-like nanodisks augment chemotherapy","volume":"350","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4161\/biom.22347","article-title":"Nanostructured porous Si-based nanoparticles for targeted drug delivery","volume":"2","author":"Shahbazi","year":"2012","journal-title":"Biomatter"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0175","doi-asserted-by":"crossref","first-page":"22214","DOI":"10.1021\/acsomega.9b03594","article-title":"Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor","volume":"4","author":"Angelopoulou","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biomaterials.2015.10.053","article-title":"Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy","volume":"76","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0185","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1021\/acsnano.0c02821","article-title":"Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0190","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2147\/IJN.S46327","article-title":"Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine","volume":"8","author":"Xie","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0195","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0200","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2010.07.116","article-title":"Polymer particle shape independently influences binding and internalization by macrophages","volume":"147","author":"Sharma","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0205","first-page":"1943","article-title":"Mechanistic aspects of biologically synthesized silver nanoparticles against food- and water-borne microbes, bioproc","volume":"38","author":"Krishnaraj","year":"2015","journal-title":"Biosyst. Eng."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0210","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/ijms20092152","article-title":"Enhancement of binding affinity of folate to its receptor by peptide conjugation","volume":"20","author":"Dharmatti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0215","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.2147\/IJN.S335588","article-title":"Emodin-conjugated PEGylation of Fe3O4 nanoparticles for FI\/MRI dual-modal imaging and therapy in pancreatic cancer","volume":"16","author":"Ren","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0220","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s11427-015-4965-6","article-title":"An overview of chronic myeloid leukemia and its animal models","volume":"58","author":"Ma","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0225","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1166\/jbn.2014.1940","article-title":"Shape-mediated biological effects of mesoporous silica nanoparticles","volume":"10","author":"Hao","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/1061186X.2020.1812614","article-title":"Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances","volume":"29","author":"Ghaferi","year":"2021","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0240","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031778","article-title":"Optical tweezers as a new biomedical tool to measure zeta potential of stored red blood cells","volume":"7","author":"Silva","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/adhm.201200138","article-title":"Erythrocyte-inspired delivery systems","volume":"1","author":"Hu","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0255","doi-asserted-by":"crossref","first-page":"39641","DOI":"10.1039\/C7RA05135B","article-title":"DOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancer","volume":"7","author":"Duo","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0260","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0270","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1039\/C4OB00827H","article-title":"Multivalent glycosylated nanoparticles for studying carbohydrate-protein interactions","volume":"12","author":"Adak","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0275","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11095-009-9840-3","article-title":"Properties influencing the relative binding affinity of pteroate derivatives and drug conjugates thereof to the folate receptor","volume":"26","author":"Leamon","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40580-021-00288-1","article-title":"Quantifying and controlling bond multivalency for advanced nanoparticle targeting to cells","volume":"8","author":"Makhani","year":"2021","journal-title":"Nano Converg."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0285","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1021\/acsomega.8b01619","article-title":"Folic acid-conjugated cellulose nanocrystals show high folate-receptor binding affinity and uptake by KB and breast cancer cells","volume":"3","author":"Bittleman","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12185-012-1196-5","article-title":"Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells","volume":"96","author":"Cruet-Hennequart","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jtice.2018.03.048","article-title":"A pH stimuli thiol modified mesoporous silica nanoparticles: doxorubicin carrier for cancer therapy","volume":"87","author":"Velusamy","year":"2018","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0300","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2010.04.007","article-title":"Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks","volume":"146","author":"Doshi","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.022_bb0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.beha.2009.04.004","article-title":"CML: a model for targeted therapy","volume":"22","author":"Cilloni","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.jconrel.2023.01.022_bb0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/16078454.2021.1945235","article-title":"The effect of Go6976 on chronic myeloid leukemia in vitro and in vivo","volume":"26","author":"Cao","year":"2021","journal-title":"Hematology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:35:53Z","timestamp":1759163753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":65,"alternative-id":["S0168365923000238"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cHook&Loop\u201d multivalent interactions based on disk-shaped nanoparticles strengthen active targeting","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}